Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-25-017640
Filing Date
2025-10-09
Accepted
2025-10-09 17:15:26
Documents
20
Period of Report
2025-10-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A formpre14a.htm   iXBRL PRE 14A 537702
2 GRAPHIC formpre14a_001.jpg GRAPHIC 113467
3 GRAPHIC formpre14a_002.jpg GRAPHIC 56498
4 GRAPHIC proxy_001.jpg GRAPHIC 319391
5 GRAPHIC proxy_002.jpg GRAPHIC 238285
  Complete submission text file 0001493152-25-017640.txt   2951703

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bmra-20250531.xsd EX-101.SCH 5071
7 XBRL DEFINITION FILE bmra-20250531_def.xml EX-101.DEF 9172
8 XBRL LABEL FILE bmra-20250531_lab.xml EX-101.LAB 61622
9 XBRL PRESENTATION FILE bmra-20250531_pre.xml EX-101.PRE 43526
22 EXTRACTED XBRL INSTANCE DOCUMENT formpre14a_htm.xml XML 99431
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: PRE 14A | Act: 34 | File No.: 001-37863 | Film No.: 251385845
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)